WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line
In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients co...
Saved in:
Published in | Immunopharmacology and immunotoxicology Vol. 34; no. 1; pp. 56 - 65 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare
01.02.2012
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0892-3973 1532-2513 1532-2513 |
DOI | 10.3109/08923973.2011.574704 |
Cover
Loading…
Abstract | In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses. |
---|---|
AbstractList | In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses. In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses.In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses. In the present study, we investigated the possibility that the WNT/ beta -catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/ beta -catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/ beta -catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/ beta -catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3 beta and accumulation of beta -catenin protein. It was found that beta -catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in beta -catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor- Kappa B (NF- Kappa B) activity was also significantly increased in beta -catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that beta -catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses. |
Author | Lee, Haeyong Yoon, Yoosik Bae, Sungmin Choi, Byoung Whui |
Author_xml | – sequence: 1 givenname: Haeyong surname: Lee fullname: Lee, Haeyong email: thanks@cau.ac.kr, thanks@cau.ac.kr organization: Department of Microbiology, Chung-Ang University College of Medicine – sequence: 2 givenname: Sungmin surname: Bae fullname: Bae, Sungmin email: thanks@cau.ac.kr, thanks@cau.ac.kr organization: Department of Microbiology, Chung-Ang University College of Medicine – sequence: 3 givenname: Byoung Whui surname: Choi fullname: Choi, Byoung Whui email: thanks@cau.ac.kr, thanks@cau.ac.kr organization: Division of Pulmonary and Allergy Disease, Department of Internal Medicine, Chung-Ang University College of Medicine – sequence: 4 givenname: Yoosik surname: Yoon fullname: Yoon, Yoosik email: thanks@cau.ac.kr, thanks@cau.ac.kr organization: Department of Microbiology, Chung-Ang University College of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21699440$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFu1DAURS1URKctf4BQdqwytR3HiVmAqgpopREgWtSl9cZ5aVwl9tR2VM1v8SF8E4lmigSLdmXp-dyr9-49IgfOOyTkDaPLglF1SmvFC1UVS04ZW5aVqKh4QRasLHjOS1YckMWM5DNzSI5ivKOUqYqWr8ghZ1IpIeiC3N58vT79_Ss3kNBZl20gdQ-wzWzMBt-M_TRusmkOMXUDzN8WXYoZuCZbfb_KY7LDnvpxdsOlWFbZACb4TQe3mBns-6y3Dk_Iyxb6iK_37zH5-fnT9flFvvr25fL8bJUbIVTKlZGKm7o1ooG2LpEhMi4NRS4VFgJUAxTLBrBaszWTsm2M4RUH2q6xVsCKY_Ju57sJ_n7EmPRg47wFOPRj1IrLKRQmy-dJxhkta6km8u2eHNcDNnoT7ABhqx9TnACxA6a7YwzY_kUY1XNZ-rEsPZeld2VNsvf_yYxNU8DepQC2f078cSe2rvVhgAcf-kYn2PY-tAGcsXFWP-nw4R-HDqFPnYGA-s6PwU01Pb3CH54RwFU |
CitedBy_id | crossref_primary_10_1155_2024_8869510 crossref_primary_10_1177_1753465813503029 crossref_primary_10_1182_blood_2015_02_622233 crossref_primary_10_4162_nrp_2015_9_1_3 crossref_primary_10_1016_j_pharmthera_2018_02_009 crossref_primary_10_1042_BSR20180548 crossref_primary_10_1007_s00011_013_0674_4 crossref_primary_10_3892_ijmm_2015_2424 crossref_primary_10_1002_jcb_24441 crossref_primary_10_1371_journal_pone_0149257 crossref_primary_10_2147_JIR_S319416 crossref_primary_10_1007_s00011_015_0891_0 crossref_primary_10_1155_2020_1061407 crossref_primary_10_1007_s10753_013_9679_y crossref_primary_10_3727_096504016X14721731148893 crossref_primary_10_1007_s11033_016_4007_x crossref_primary_10_1159_000507250 crossref_primary_10_1177_20587392211059362 crossref_primary_10_3727_096504013X13793555706803 crossref_primary_10_1021_acs_analchem_0c01823 crossref_primary_10_1016_j_clinbiochem_2012_05_002 crossref_primary_10_1093_intimm_dxaa002 crossref_primary_10_1007_s00436_020_07000_y crossref_primary_10_1016_j_drudis_2017_09_001 crossref_primary_10_1038_s41598_017_08711_6 crossref_primary_10_3389_fcvm_2021_701279 crossref_primary_10_1016_j_toxlet_2020_10_002 crossref_primary_10_2147_DDDT_S344309 crossref_primary_10_1007_s00011_012_0474_2 crossref_primary_10_1186_s12964_024_01608_8 crossref_primary_10_3168_jds_2022_22983 crossref_primary_10_1038_s41467_025_56967_8 crossref_primary_10_3389_fcell_2021_641404 crossref_primary_10_1016_j_gene_2018_04_002 crossref_primary_10_1007_s12272_013_0269_1 crossref_primary_10_1016_j_intimp_2013_06_011 crossref_primary_10_1016_j_molimm_2014_02_002 crossref_primary_10_1016_j_jep_2021_114526 crossref_primary_10_1111_jcmm_12190 crossref_primary_10_1016_j_biopha_2018_02_057 crossref_primary_10_3389_fimmu_2019_01813 crossref_primary_10_1016_j_fitote_2017_10_015 crossref_primary_10_3892_mmr_2015_3632 crossref_primary_10_3892_mmr_2017_6992 crossref_primary_10_1161_ATVBAHA_118_311059 crossref_primary_10_1016_j_molimm_2019_12_013 |
Cites_doi | 10.1073/pnas.96.10.5522 10.4049/jimmunol.167.12.6786 10.1161/STROKEAHA.107.492231 10.1016/0165-2478(94)00160-X 10.1016/S1074-7613(02)00449-1 10.1016/S0959-437X(98)80068-3 10.1182/blood.V84.9.2840.2840 10.1021/jm031101l 10.1210/jcem.87.5.8447 10.1517/14728222.11.5.613 10.1016/S0761-8425(09)73684-8 10.1016/0091-6749(92)90223-O 10.1038/sj.cdd.4401850 10.1165/ajrcmb.18.3.2972 10.1146/annurev.cellbio.14.1.59 10.3109/02770901003686472 10.1164/ajrccm/136.1.225 10.1038/18884 10.1128/MCB.13.10.6231 10.1182/blood.V89.11.4100 10.1128/MCB.10.5.2327 10.1038/labinvest.3700545 10.4049/jimmunol.164.5.2602 10.1006/geno.1994.1493 10.4049/jimmunol.174.6.3650 10.1371/journal.pone.0008979 10.1183/09031936.98.12010221 10.1002/ijc.23600 10.1002/jlb.60.1.8 10.1615/CritRevImmunol.v25.i2.10 10.2174/187152810792231904 10.1194/jlr.R800063-JLR200 10.1016/S1380-2933(97)10005-7 10.1128/MCB.10.4.1498 10.1146/annurev.cellbio.21.122303.115827 10.1146/annurev.iy.13.040195.001343 10.1371/journal.pmed.1000145 10.1046/j.1365-2249.1999.00861.x 10.1038/ng0697-161 10.4049/jimmunol.181.10.6797 10.4049/jimmunol.142.1.144 10.1073/pnas.90.21.10193 10.1074/jbc.M201304200 10.1385/CRIAI:28:3:257 10.1016/S1534-5807(03)00266-1 10.1089/ars.2006.8.1573 10.1074/jbc.M508221200 10.1111/j.1600-065X.2007.00554.x 10.1111/j.1398-9995.2006.01305.x 10.1016/0732-8893(90)90016-O 10.1074/jbc.M710396200 10.1177/1753425907088244 10.1152/ajpcell.00319.2004 10.1111/j.1365-2141.1994.tb04905.x 10.1242/jcs.02826 10.1161/ATVBAHA.107.160952 10.1111/j.1742-4658.2010.07700.x 10.1007/s11883-009-0036-4 10.1016/S0161-5890(02)00210-9 10.1242/jcs.00089 10.1159/000126450 10.1006/meth.2001.1262 10.1126/science.1071549 10.1074/jbc.M203298200 10.1152/ajpheart.00256.2001 10.4049/jimmunol.153.4.1818 10.1182/blood-2007-07-102137 10.4049/jimmunol.166.7.4713 10.1016/j.cellsig.2008.08.022 10.1067/mai.2003.169 |
ContentType | Journal Article |
Copyright | 2012 Informa Healthcare USA, Inc. 2012 |
Copyright_xml | – notice: 2012 Informa Healthcare USA, Inc. 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
DOI | 10.3109/08923973.2011.574704 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1532-2513 |
EndPage | 65 |
ExternalDocumentID | 21699440 10_3109_08923973_2011_574704 574704 |
Genre | Research Article Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GJ 00X 0BK 0R~ 29I 36B 4.4 53G 5GY 5RE 5VS AACCU AAJNR AALIY AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABCRQ ABDBF ABEIZ ABLKL ABPTK ABUPF ACENM ACFUF ACGEJ ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AENEX AEOZL AEYQI AFAUU AFKVX AFQCT AFWLO AGAFX AGDLA AGFJD AGRBW AGYJP AI. AIJEM AIRBT AJEBJ AJWEG AJXHO AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AWYRJ BABNJ BLEHA BOHLJ BVLLS CAG CCCUG COF CS3 DEIEU DKSSO DLVIE DTRLO DU5 DZHFC EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ JFOCU KRBQP KSSTO KWAYT KYCEM LJTGL M44 M4Z MK0 O9- QRXOQ RNANH RVRKI SV3 TFDNU TFL TFW TUS UHWXJ V1S VH1 ZGI ~1N ABJNI ABLIJ ABXYU ACIEZ ACUHS ALYBC TBQAZ TDBHL TERGH TUROJ AAGDL AAYXX ABWVI ACKYO ADYSH AFRVT AOYHP CITATION NUSFT TASJS CGR CUY CVF ECM EIF NPM 7X8 7T5 AMPGV H94 |
ID | FETCH-LOGICAL-c449t-9c692c8fc4daf85e1ee126c0e269e34a9da0e5dae7b1b166fdcc272a0fbe89a13 |
ISSN | 0892-3973 1532-2513 |
IngestDate | Fri Jul 11 01:05:00 EDT 2025 Tue Aug 05 11:12:31 EDT 2025 Mon Jul 21 05:59:34 EDT 2025 Wed Jul 16 07:19:16 EDT 2025 Thu Apr 24 22:50:18 EDT 2025 Wed Dec 25 09:04:35 EST 2024 Tue Jul 04 19:20:30 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c449t-9c692c8fc4daf85e1ee126c0e269e34a9da0e5dae7b1b166fdcc272a0fbe89a13 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 21699440 |
PQID | 912105869 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_926892165 proquest_miscellaneous_912105869 pubmed_primary_21699440 crossref_citationtrail_10_3109_08923973_2011_574704 crossref_primary_10_3109_08923973_2011_574704 informaworld_taylorfrancis_310_3109_08923973_2011_574704 informahealthcare_journals_10_3109_08923973_2011_574704 |
PublicationCentury | 2000 |
PublicationDate | 20120200 2/1/2012 2012-02-00 2012-Feb 20120201 |
PublicationDateYYYYMMDD | 2012-02-01 |
PublicationDate_xml | – month: 2 year: 2012 text: 20120200 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Immunopharmacology and immunotoxicology |
PublicationTitleAlternate | Immunopharmacol Immunotoxicol |
PublicationYear | 2012 |
Publisher | Informa Healthcare Taylor & Francis |
Publisher_xml | – name: Informa Healthcare – name: Taylor & Francis |
References | CIT0071 CIT0074 Wodarz A. (CIT0020) 1998; 14 Jirik F.R. (CIT0038) 1989; 142 Hirotani T. (CIT0041) 2005; 174 Kraus C. (CIT0017) 1994; 23 Kawahara T. (CIT0053) 2005; 288 Yachida M. (CIT0066) 1999; 116 Keshav S. (CIT0001) 1990; 13 Kim S.Y. (CIT0034) 2010; 5 Cadigan K.M. (CIT0021) 2006; 119 Akashi K. (CIT0056) 1994; 87 Duan Y. (CIT0024) 2007; 87 Diehl S. (CIT0065) 2002; 39 Pereira C.P. (CIT0044) 2009; 11 Weinbrenner A. (CIT0032) 2002; 87 Gong R. (CIT0045) 2008; 283 Kraus-Filarska M. (CIT0052) 1998; 8 Paine R. (CIT0003) 2000; 164 Huelsken J. (CIT0023) 2002; 115 CIT0040 Lee J.G. (CIT0054) 2008; 20 von Asmuth E.J. (CIT0036) 1994; 5 Moon R.T. (CIT0018) 2002; 296 Romero L.I. (CIT0037) 1993; 57 Guha M. (CIT0039) 2002; 277 Livak K.J. (CIT0033) 2001; 25 Monick M.M. (CIT0026) 2001; 166 Larché M. (CIT0063) 2003; 111 Maggi E. (CIT0064) 1998; 3 Shibata N. (CIT0002) 2009; 50 Kim J.S. (CIT0025) 2010; 277 Hersperger R. (CIT0031) 2004; 47 CIT0008 Shapira L. (CIT0010) 1994; 153 Collart M.A. (CIT0013) 1990; 10 CIT0050 Caillaud D. (CIT0048) 2009; 26 Wright G. (CIT0012) 2002; 282 Wang Y. (CIT0035) 2008; 123 West A.P. (CIT0011) 2006; 22 Hiscott J. (CIT0014) 1993; 13 Tetsu O. (CIT0046) 1999; 398 Kawai T. (CIT0009) 2006; 13 George S.J. (CIT0043) 2008; 28 Bancroft G.J. (CIT0004) 1994; 43 Sweet M.J. (CIT0007) 1996; 60 Matsusaka T. (CIT0016) 1993; 90 Mashima R. (CIT0060) 2005; 280 Tso A.R. (CIT0073) 2007; 38 CIT0015 Ye B.H. (CIT0067) 1997; 16 Wang H. (CIT0028) 2008; 181 Osugi Y. (CIT0058) 1997; 89 Kidd P. (CIT0061) 2003; 8 Thiele A. (CIT0027) 2001; 167 Nakagawa R. (CIT0059) 2002; 17 Marini M. (CIT0051) 1992; 89 Rabe B. (CIT0069) 2008; 111 Shtutman M. (CIT0047) 1999; 96 Cline M.J. (CIT0057) 1994; 84 Trinchieri G. (CIT0005) 1995; 13 CIT0022 Crane I.J. (CIT0062) 2005; 25 Rokutan K. (CIT0055) 2006; 8 Gray S. (CIT0042) 2002; 277 Veeman M.T. (CIT0019) 2003; 5 Kuo Chou T.N. (CIT0049) 2010; 47 Rose-John S. (CIT0070) 2007; 11 Whiteley W. (CIT0072) 2009; 6 Yan Z.Q. (CIT0006) 2007; 219 CIT0029 Bousquet J. (CIT0030) 2007; 62 Chalaris A. (CIT0068) 2010 |
References_xml | – volume: 96 start-page: 5522 year: 1999 ident: CIT0047 publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.96.10.5522 – year: 2010 ident: CIT0068 publication-title: Eur. J. Cell Biol – volume: 167 start-page: 6786 year: 2001 ident: CIT0027 publication-title: J. Immunol doi: 10.4049/jimmunol.167.12.6786 – volume: 38 start-page: 3070 year: 2007 ident: CIT0073 publication-title: Stroke doi: 10.1161/STROKEAHA.107.492231 – volume: 43 start-page: 67 year: 1994 ident: CIT0004 publication-title: Immunol. Lett doi: 10.1016/0165-2478(94)00160-X – volume: 17 start-page: 677 year: 2002 ident: CIT0059 publication-title: Immunity doi: 10.1016/S1074-7613(02)00449-1 – ident: CIT0022 doi: 10.1016/S0959-437X(98)80068-3 – volume: 84 start-page: 2840 year: 1994 ident: CIT0057 publication-title: Blood doi: 10.1182/blood.V84.9.2840.2840 – volume: 47 start-page: 4950 year: 2004 ident: CIT0031 publication-title: J. Med. Chem doi: 10.1021/jm031101l – volume: 87 start-page: 2160 year: 2002 ident: CIT0032 publication-title: J. Clin. Endocrinol. Metab doi: 10.1210/jcem.87.5.8447 – volume: 11 start-page: 613 year: 2007 ident: CIT0070 publication-title: Expert Opin. Ther. Targets doi: 10.1517/14728222.11.5.613 – volume: 26 start-page: 893 year: 2009 ident: CIT0048 publication-title: Rev. Mal. Respir doi: 10.1016/S0761-8425(09)73684-8 – volume: 89 start-page: 1001 year: 1992 ident: CIT0051 publication-title: J. Allergy Clin. Immunol doi: 10.1016/0091-6749(92)90223-O – volume: 13 start-page: 816 year: 2006 ident: CIT0009 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401850 – ident: CIT0008 doi: 10.1165/ajrcmb.18.3.2972 – volume: 14 start-page: 59 year: 1998 ident: CIT0020 publication-title: Annu. Rev. Cell Dev. Biol doi: 10.1146/annurev.cellbio.14.1.59 – volume: 47 start-page: 532 year: 2010 ident: CIT0049 publication-title: J. Asthma doi: 10.3109/02770901003686472 – ident: CIT0029 doi: 10.1164/ajrccm/136.1.225 – volume: 398 start-page: 422 year: 1999 ident: CIT0046 publication-title: Nature doi: 10.1038/18884 – volume: 13 start-page: 6231 year: 1993 ident: CIT0014 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.13.10.6231 – volume: 5 start-page: 301 year: 1994 ident: CIT0036 publication-title: Eur. Cytokine Netw – volume: 89 start-page: 4100 year: 1997 ident: CIT0058 publication-title: Blood doi: 10.1182/blood.V89.11.4100 – ident: CIT0015 doi: 10.1128/MCB.10.5.2327 – volume: 87 start-page: 613 year: 2007 ident: CIT0024 publication-title: Lab. Invest doi: 10.1038/labinvest.3700545 – volume: 164 start-page: 2602 year: 2000 ident: CIT0003 publication-title: J. Immunol doi: 10.4049/jimmunol.164.5.2602 – volume: 23 start-page: 272 year: 1994 ident: CIT0017 publication-title: Genomics doi: 10.1006/geno.1994.1493 – volume: 174 start-page: 3650 year: 2005 ident: CIT0041 publication-title: J. Immunol doi: 10.4049/jimmunol.174.6.3650 – volume: 5 start-page: e8979 year: 2010 ident: CIT0034 publication-title: PLoS ONE doi: 10.1371/journal.pone.0008979 – ident: CIT0050 doi: 10.1183/09031936.98.12010221 – volume: 123 start-page: 561 year: 2008 ident: CIT0035 publication-title: Int. J. Cancer doi: 10.1002/ijc.23600 – volume: 60 start-page: 8 year: 1996 ident: CIT0007 publication-title: J. Leukoc. Biol doi: 10.1002/jlb.60.1.8 – volume: 25 start-page: 75 year: 2005 ident: CIT0062 publication-title: Crit. Rev. Immunol doi: 10.1615/CritRevImmunol.v25.i2.10 – ident: CIT0074 doi: 10.2174/187152810792231904 – volume: 50 start-page: S277 year: 2009 ident: CIT0002 publication-title: J. Lipid Res doi: 10.1194/jlr.R800063-JLR200 – volume: 3 start-page: 233 year: 1998 ident: CIT0064 publication-title: Immunotechnology doi: 10.1016/S1380-2933(97)10005-7 – volume: 10 start-page: 1498 year: 1990 ident: CIT0013 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.10.4.1498 – volume: 8 start-page: 94 year: 1998 ident: CIT0052 publication-title: J. Investig. Allergol. Clin. Immunol – volume: 22 start-page: 409 year: 2006 ident: CIT0011 publication-title: Annu. Rev. Cell Dev. Biol doi: 10.1146/annurev.cellbio.21.122303.115827 – volume: 13 start-page: 251 year: 1995 ident: CIT0005 publication-title: Annu. Rev. Immunol doi: 10.1146/annurev.iy.13.040195.001343 – volume: 8 start-page: 223 year: 2003 ident: CIT0061 publication-title: Altern. Med. Rev – volume: 6 start-page: e1000145 year: 2009 ident: CIT0072 publication-title: PLoS Med doi: 10.1371/journal.pmed.1000145 – volume: 116 start-page: 140 year: 1999 ident: CIT0066 publication-title: Clin. Exp. Immunol doi: 10.1046/j.1365-2249.1999.00861.x – volume: 16 start-page: 161 year: 1997 ident: CIT0067 publication-title: Nat. Genet doi: 10.1038/ng0697-161 – volume: 181 start-page: 6797 year: 2008 ident: CIT0028 publication-title: J. Immunol doi: 10.4049/jimmunol.181.10.6797 – volume: 142 start-page: 144 year: 1989 ident: CIT0038 publication-title: J. Immunol doi: 10.4049/jimmunol.142.1.144 – volume: 90 start-page: 10193 year: 1993 ident: CIT0016 publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.90.21.10193 – volume: 277 start-page: 34322 year: 2002 ident: CIT0042 publication-title: J. Biol. Chem doi: 10.1074/jbc.M201304200 – ident: CIT0071 doi: 10.1385/CRIAI:28:3:257 – volume: 5 start-page: 367 year: 2003 ident: CIT0019 publication-title: Dev. Cell doi: 10.1016/S1534-5807(03)00266-1 – volume: 8 start-page: 1573 year: 2006 ident: CIT0055 publication-title: Antioxid. Redox Signal doi: 10.1089/ars.2006.8.1573 – volume: 280 start-page: 41289 year: 2005 ident: CIT0060 publication-title: J. Biol. Chem doi: 10.1074/jbc.M508221200 – volume: 219 start-page: 187 year: 2007 ident: CIT0006 publication-title: Immunol. Rev doi: 10.1111/j.1600-065X.2007.00554.x – volume: 62 start-page: 102 year: 2007 ident: CIT0030 publication-title: Allergy doi: 10.1111/j.1398-9995.2006.01305.x – volume: 13 start-page: 439 year: 1990 ident: CIT0001 publication-title: Diagn. Microbiol. Infect. Dis doi: 10.1016/0732-8893(90)90016-O – volume: 283 start-page: 7401 year: 2008 ident: CIT0045 publication-title: J. Biol. Chem doi: 10.1074/jbc.M710396200 – ident: CIT0040 doi: 10.1177/1753425907088244 – volume: 288 start-page: C450 year: 2005 ident: CIT0053 publication-title: Am. J. Physiol., Cell Physiol doi: 10.1152/ajpcell.00319.2004 – volume: 87 start-page: 243 year: 1994 ident: CIT0056 publication-title: Br. J. Haematol doi: 10.1111/j.1365-2141.1994.tb04905.x – volume: 119 start-page: 395 year: 2006 ident: CIT0021 publication-title: J. Cell. Sci doi: 10.1242/jcs.02826 – volume: 28 start-page: 400 year: 2008 ident: CIT0043 publication-title: Arterioscler. Thromb. Vasc. Biol doi: 10.1161/ATVBAHA.107.160952 – volume: 277 start-page: 2830 year: 2010 ident: CIT0025 publication-title: FEBS J doi: 10.1111/j.1742-4658.2010.07700.x – volume: 11 start-page: 236 year: 2009 ident: CIT0044 publication-title: Curr. Atheroscler. Rep doi: 10.1007/s11883-009-0036-4 – volume: 39 start-page: 531 year: 2002 ident: CIT0065 publication-title: Mol. Immunol doi: 10.1016/S0161-5890(02)00210-9 – volume: 115 start-page: 3977 year: 2002 ident: CIT0023 publication-title: J. Cell. Sci doi: 10.1242/jcs.00089 – volume: 57 start-page: 892 year: 1993 ident: CIT0037 publication-title: Neuroendocrinology doi: 10.1159/000126450 – volume: 25 start-page: 402 year: 2001 ident: CIT0033 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 296 start-page: 1644 year: 2002 ident: CIT0018 publication-title: Science doi: 10.1126/science.1071549 – volume: 277 start-page: 32124 year: 2002 ident: CIT0039 publication-title: J. Biol. Chem doi: 10.1074/jbc.M203298200 – volume: 282 start-page: H872 year: 2002 ident: CIT0012 publication-title: Am. J. Physiol. Heart Circ. Physiol doi: 10.1152/ajpheart.00256.2001 – volume: 153 start-page: 1818 year: 1994 ident: CIT0010 publication-title: J. Immunol doi: 10.4049/jimmunol.153.4.1818 – volume: 111 start-page: 1021 year: 2008 ident: CIT0069 publication-title: Blood doi: 10.1182/blood-2007-07-102137 – volume: 166 start-page: 4713 year: 2001 ident: CIT0026 publication-title: J. Immunol doi: 10.4049/jimmunol.166.7.4713 – volume: 20 start-page: 2266 year: 2008 ident: CIT0054 publication-title: Cell. Signal doi: 10.1016/j.cellsig.2008.08.022 – volume: 111 year: 2003 ident: CIT0063 publication-title: J. Allergy Clin. Immunol doi: 10.1067/mai.2003.169 |
SSID | ssj0019705 |
Score | 2.1277382 |
Snippet | In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory... In the present study, we investigated the possibility that the WNT/ beta -catenin pathway plays a role in inflammatory responses both in an human inflammatory... |
SourceID | proquest pubmed crossref informaworld informahealthcare |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 56 |
SubjectTerms | Adaptor Proteins, Signal Transducing - immunology Adaptor Proteins, Signal Transducing - metabolism Animals Asthma - immunology Asthma - metabolism Asthma - pathology Axin Protein - immunology Axin Protein - metabolism beta Catenin - immunology beta Catenin - metabolism Cell Line cytokine Dishevelled Proteins Female Glycogen Synthase Kinase 3 - immunology Glycogen Synthase Kinase 3 - metabolism Glycogen Synthase Kinase 3 beta Humans hyperactivation IL-6 Inflammation Interleukin-6 - immunology Interleukin-6 - metabolism Lipopolysaccharides - pharmacology Low Density Lipoprotein Receptor-Related Protein-6 - immunology Low Density Lipoprotein Receptor-Related Protein-6 - metabolism Male Mice NF-kappa B - immunology NF-kappa B - metabolism NF-κB Phosphoproteins - immunology Phosphoproteins - metabolism Wnt Proteins - immunology Wnt Proteins - metabolism Wnt Signaling Pathway - drug effects Wnt Signaling Pathway - immunology |
Title | WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line |
URI | https://www.tandfonline.com/doi/abs/10.3109/08923973.2011.574704 https://www.ncbi.nlm.nih.gov/pubmed/21699440 https://www.proquest.com/docview/912105869 https://www.proquest.com/docview/926892165 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6F9MIFlXd4aQ-0l9StvX7uMQmtAoKqglTpzVrb6zhqkyDsCMLPQvwOfhMz2bXjhJJCL060ml3Lns_j2fHMN4S89lJug-HzDCsV0nDcmBk8MW2D-6nJfVPaTGJA_8Op1z933l24F43Gz1rW0ryIDuPv19aV3EarMAZ6xSrZ_9BstSgMwH_QLxxBw3D8Jx0PTwcwea93vNdlBqY2aabU7KtYYKfyySzB7lwS-ZXaIi-yiSiJVBU18_uzTwY84xMt9bEzBM_l0G9PBHb2yjCfByP77avy67t2Y99iVQkKlLTXmsVpOVzMvo3jtWi9zvbpCyyXGa2CpzovaDqajCuM9rLZMsGgu0A71B5m8_HKMqkUAfjNx5f1eAUmfqzlfqxXWWF6W93icWaAg6QsniwtMjPACbPrJlvHP-vQVPbX9WpvctWEYvMdYSuKVTwXnkqxuLqwq1JtkDfYt2GPhBPCUjxE8VCJ3yE7DDYnrEl2Ot033ZPq6xWAfJk6W16OKtnEdY6uO-2aS7SrCXOz6v5skOj-fSu0dIkGu-Se3svQjgLmfdKQ0wdk_0yhYnFAB6vavvyA7tOzGl4ekhGg9-jXjxK3VOOWjnNa4ZbCuMItLXFLAWh0Hbe0xC1d4ZYibini9hE5Pzke9PqGbvthxI7DC4PHHmdxkMZOItLAlZaUFvNiUzKPS9sRPBGmdBMh_ciKLM9LkzhmPhNmGsmAC8t-TJrT2VQ-JTTwHSGkSGE11wFjFQRpYkYiStLINrkULWKXdz6MNSc-tma5CrfpvUWMatZnxQlzg7z_h1JDbUbyG2YGddWHxTKKl6qWOzht21RawiSENwbedDGVs3kecuQMdAOPbxFhHixpeW6LPFEIqy4URjl3HPPZrS_qObm7sgsvSLP4MpcvwbMvolf6QfoN0ifyZQ |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=WNT%2F%CE%B2-catenin+pathway+is+modulated+in+asthma+patients+and+LPS-stimulated+RAW264.7+macrophage+cell+line&rft.jtitle=Immunopharmacology+and+immunotoxicology&rft.au=Lee%2C+Haeyong&rft.au=Bae%2C+Sungmin&rft.au=Choi%2C+Byoung+Whui&rft.au=Yoon%2C+Yoosik&rft.date=2012-02-01&rft.pub=Informa+Healthcare&rft.issn=0892-3973&rft.eissn=1532-2513&rft.volume=34&rft.issue=1&rft.spage=56&rft.epage=65&rft_id=info:doi/10.3109%2F08923973.2011.574704&rft.externalDocID=10_3109_08923973_2011_574704 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-3973&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-3973&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-3973&client=summon |